EQS-News: Heidelberg Pharma AG / Key word(s): 9 Month figuresHeidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2023 12.10.2023 / 07:09 CET/CESTThe issuer is solely responsible for the content of this announcement.Heidelberg Pharma AG: Interim Management Statement on the First Nine Months.
RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that RHB-107 (upamostat)3 has been accepted for inclusion in the Austere environments Consortium for Enhanced Sepsis Outcomes' (ACESO) U.S. Government-supported PROTECT multinational platform trial for early COVID-19 outpatient treatment to be conducted in the U.S., Thailand, Ivory Coast and South Africa. The Company also announced that the Phase 2 study, predominantly funde
The firm will develop a rapid test for its LightDeck analyzer to detect C-reactive proteins, inducible-proteins 10 (IP-10 or CXCL-10), and other inflammatory markers.
Award-Winning Bioengineering Grad Student Has Sense for Medical Innovation utdallas.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from utdallas.edu Daily Mail and Mail on Sunday newspapers.